Dave Madge, PhD

Vice President, Research Services Division at WuXi AppTec

Speaker

Dr Dave Madge is Vice President of Discovery Services in WuXi AppTec. In this role Dave leads business development in Europe and Israel, alongside a portfolio of strategic initiatives across multiple therapeutic areas and modalities.

Prior to joining WuXi AppTec, in 2014, Dave was VP, Research, for the ion channel drug discovery company Xention Ltd, in Cambridge, UK, developing new molecules for cardiovascular and respiratory disorders. Before Xention Dave was based at University College London, as part of an integrated biomedical research group, and was responsible for developing new therapeutic discovery projects into funded biotech companies.

Dave has a PhD in Medicinal Chemistry from Imperial College, London, and started his career at The Wellcome Foundation in the medicinal chemistry team.